http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110711198-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110711198-B |
| titleOfInvention | Application of D-mannose in the preparation of antidepressant drugs |
| abstract | The invention discloses the antidepressant activity of D-mannose, which can be used for preparing antidepressant drugs and health care products. Through animal modeling experiments, animal behavioral experiments and in vitro experiments. For the first time, it was verified that D-mannose can alleviate depression-related behaviors, fight anxiety, and significantly reduce the levels of neurotransmitters in the hippocampus, hypothalamus, and prefrontal lobe of mouse brains. Based on the good antidepressant activity of D-mannose, the present invention correspondingly protects the application of D-mannose in the preparation of antidepressant drugs and health care products, and provides a pharmaceutical composition with antidepressant effect, an antidepressant Depression medication and an antidepressant supplement. |
| priorityDate | 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.